PTK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.588400E-01
Normal-vs-Stage2
5.929400E-01
Normal-vs-Stage3
4.004600E-01
Normal-vs-Stage4
6.331600E-01
Stage1-vs-Stage2
8.625200E-01
Stage1-vs-Stage3
6.063900E-02
Stage1-vs-Stage4
9.557600E-01
Stage2-vs-Stage3
1.931360E-01
Stage2-vs-Stage4
9.879200E-01
Stage3-vs-Stage4
2.742000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.902400E-01
Normal-vs-AfricanAmerican
8.974000E-01
Normal-vs-Asian
4.702600E-01
Caucasian-vs-AfricanAmerican
3.768200E-01
Caucasian-vs-Asian
7.944000E-01
AfricanAmerican-vs-Asian
2.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.949800E-01
Normal-vs-Female
5.497600E-01
Male-vs-Female
8.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.148400E-01
Normal-vs-Age(41-60Yrs)
3.720400E-01
Normal-vs-Age(61-80Yrs)
7.111600E-01
Normal-vs-Age(81-100Yrs)
5.258400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.17499999999715E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.337700E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.103760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.040200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.526200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.195600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.011400E-01
Normal-vs-Daily Drinker
6.848000E-01
Normal-vs-Weekly Drinker
8.336200E-01
Normal-vs-Occasional Drinker
1.880970E-01
Normal-vs-Social Drinker
6.442400E-01
Non Drinker-vs-Daily Drinker
7.930600E-01
Non Drinker-vs-Weekly Drinker
8.130000E-01
Non Drinker-vs-Occasional Drinker
1.672320E-02
Non Drinker-vs-Social Drinker
9.262200E-01
Daily Drinker-vs-Weekly Drinker
6.125600E-01
Daily Drinker-vs-Occasional Drinker
3.338200E-02
Daily Drinker-vs-Social Drinker
8.669600E-01
Weekly Drinker-vs-Occasional Drinker
1.193820E-02
Weekly Drinker-vs-Social Drinker
6.773800E-01
Occasional Drinker-vs-Social Drinker
2.250400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.050200E-01
Normal-vs-Grade 2
9.756100E-02
Normal-vs-Grade 3
1.693950E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.360400E-01
Grade 1-vs-Grade 3
3.222000E-01
Grade 1-vs-Grade 4
2.050200E-01
Grade 2-vs-Grade 3
9.118100E-02
Grade 2-vs-Grade 4
9.756100E-02
Grade 3-vs-Grade 4
1.693950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.768000E-01
Normal-vs-NonDiabetic
5.191400E-01
Diabetic-vs-NonDiabetic
3.845900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.022400E-01
Normal-vs-NoPancreatitis
5.903800E-01
Pancreatitis-vs-NoPancreatitis
9.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.814600E-01
Normal-vs-N1
5.949200E-01
N0-vs-N1
6.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.676220E-01
Normal-vs-TP53-NonMutant
6.968400E-01
TP53-Mutant-vs-TP53-NonMutant
3.97570000000291E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
